{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:10:29Z","timestamp":1793059829089,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00774-020-01142-w","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:04:13Z","timestamp":1599469453000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry"],"prefix":"10.1007","volume":"39","author":[{"given":"Ashutosh Kumar","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-8778","authenticated-orcid":false,"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanhaiya","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhaker D.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"1142_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","volume":"374","author":"WD Fraser","year":"2009","unstructured":"Fraser WD (2009) Hyperparathyroidism. Lancet 374:145\u2013158","journal-title":"Lancet"},{"key":"1142_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Wermers","year":"2006","unstructured":"Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS et al (2006) Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J Bone Miner Res 21:171\u2013177","journal-title":"J Bone Miner Res"},{"key":"1142_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0004-27302006000400010","volume":"50","author":"JP Bilezikian","year":"2006","unstructured":"Bilezikian JP, Rubin M, Silverberg SJ (2006) Asymptomatic primary hyperparathyroidism. Arq Bras Endocrinol Metabol 50:647\u2013656","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1142_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/0004-2730000003381","volume":"58","author":"F Bandeira","year":"2014","unstructured":"Bandeira F, Cusano NE, Silva BC, Cassibba S, Almeida CB, Machado VC et al (2014) Bone disease in primary hyperparathyroidism. Arq Bras Endocrinol Metabol 58:553\u2013561","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1142_CR5","first-page":"694","volume":"139","author":"VN Shah","year":"2014","unstructured":"Shah VN, Bhadada S, Bhansali A, Behera A, Mittal B (2014) Changes in clinical and biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res 139:694\u2013699","journal-title":"Indian J Med Res"},{"key":"1142_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0022-3859.65279","volume":"56","author":"RA Gopal","year":"2010","unstructured":"Gopal RA, Acharya SV, Bandgar T, Menon PS, Dalvi AN, Shah NS (2010) Clinical profile of primary hyperparathyroidism from western India: a single center experience. J Postgrad Med 56:79\u201384","journal-title":"J Postgrad Med"},{"key":"1142_CR7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","volume":"36","author":"SK Bhadada","year":"2018","unstructured":"Bhadada SK, Arya AK, Mukhopadhyay S, Khadgawat R, Sukumar S, Lodha S et al (2018) Primary hyperparathyroidism: insights from the Indian PHPT registry. J Bone Miner Metab 36:238\u2013245","journal-title":"J Bone Miner Metab"},{"key":"1142_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4158\/EP15951.OR","volume":"22","author":"S Hu","year":"2016","unstructured":"Hu S, Cai X, Mewani V, Wong B, Trooskin S, Wang X (2016) Impact of ethnic background on clinical characteristics and cardiovascular risk factors among patients with primary hyperparathyroidism. Endocr Pract 22:323\u2013327","journal-title":"Endocr Pract"},{"key":"1142_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0022-3859.97171","volume":"58","author":"VN Shah","year":"2012","unstructured":"Shah VN, Bhadada SK, Bhansali A, Behera A, Mittal BR, Bhavin V (2012) Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J Postgrad Med 58:107\u2013111","journal-title":"J Postgrad Med"},{"key":"1142_CR10","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1445-2197.2006.03845.x","volume":"76","author":"JJ Jacob","year":"2006","unstructured":"Jacob JJ, John M, Thomas N, Chacko A, Cherian R, Selvan B et al (2006) Does hyperparathyroidism cause pancreatitis? A South Indian experience and a review of published work. ANZ J Surg 76:740\u2013744","journal-title":"ANZ J Surg"},{"key":"1142_CR11","first-page":"607","volume":"81","author":"MM Kapur","year":"1985","unstructured":"Kapur MM, Agarwal MS, Gupta A, Misra MC, Ahuja MM (1985) Clinical and biochemical features of primary hyperparathyroidism. Indian J Med Res 81:607\u2013612","journal-title":"Indian J Med Res"},{"key":"1142_CR12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2230-8210.172237","volume":"20","author":"S Jha","year":"2016","unstructured":"Jha S, Jayaraman M, Jha A, Jha R, Modi KD, Kelwadee JV (2016) Primary hyperparathyroidism: a changing scenario in India. Indian J Endocrinol Metab 20:80\u201383","journal-title":"Indian J Endocrinol Metab"},{"key":"1142_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0377-4929.54983","volume":"52","author":"PA Sathe","year":"2009","unstructured":"Sathe PA, Madiwale CV, Kandalkar BM, Bandgar TR, Shah NS, Menon PS (2009) Primary hyperparathyroidism: a clinicopathological experience. Indian J Pathol Microbiol 52:313\u2013320","journal-title":"Indian J Pathol Microbiol"},{"key":"1142_CR14","doi-asserted-by":"crossref","first-page":"921814","DOI":"10.1155\/2011\/921814","volume":"2011","author":"PV Pradeep","year":"2011","unstructured":"Pradeep PV, Jayashree B, Mishra A, Mishra SK (2011) Systematic review of primary hyperparathyroidism in India: the past, present, and the future trends. Int J Endocrinol 2011:921814","journal-title":"Int J Endocrinol"},{"key":"1142_CR15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4103\/ijmr.IJMR_353_16","volume":"148","author":"AK Arya","year":"2018","unstructured":"Arya AK, Bhadada SK, Mukherjee S, Singh P, Rana SS, Dahiya D et al (2018) Frequency and predictors of pancreatitis in symptomatic primary hyperparathyroidism. Indian J Med Res 148:721\u2013727","journal-title":"Indian J Med Res"},{"key":"1142_CR16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.4158\/EP-2018-0268","volume":"24","author":"S Mukherjee","year":"2018","unstructured":"Mukherjee S, Bhadada SK, Arya AK, Singh P, Sood A, Dahiya D et al (2018) Primary hyperparathyroidism in the young: comparison with adult primary hyperparathyroidism. Endocr Pract 24:1051\u20131056","journal-title":"Endocr Pract"},{"key":"1142_CR17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/cen.14088","volume":"91","author":"P Singh","year":"2019","unstructured":"Singh P, Vadi SK, Saikia UN, Sood A, Dahiya D, Arya AK et al (2019) Minimally invasive parathyroid carcinoma\u2014a missing entity between parathyroid adenoma and carcinoma: scintigraphic and histological features. Clin Endocrinol (Oxf) 91:842\u2013850","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1142_CR18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1210\/jc.2012-2914","volume":"98","author":"L Zhao","year":"2013","unstructured":"Zhao L, Liu JM, He XY, Zhao HY, Sun LH, Tao B et al (2013) The changing clinical patterns of primary hyperparathyroidism in Chinese patients: data from 2000 to 2010 in a single clinical center. J Clin Endocrinol Metab 98:721\u2013728","journal-title":"J Clin Endocrinol Metab"},{"key":"1142_CR19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-017-4322-7","volume":"29","author":"B Sun","year":"2018","unstructured":"Sun B, Guo B, Wu B, Kang J, Deng X, Zhang Z et al (2018) Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016. Osteoporos Int 29:635\u2013642","journal-title":"Osteoporos Int"},{"key":"1142_CR20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4158\/EP14447.OR","volume":"21","author":"A Mithal","year":"2015","unstructured":"Mithal A, Kaur P, Singh VP, Sarin D, Rao DS (2015) Asymptomatic primary hyperparathyroidism exists in North India: retrospective data from 2 tertiary care centers. Endocr Pract 21:581\u2013585","journal-title":"Endocr Pract"},{"key":"1142_CR21","first-page":"1054","volume":"85","author":"DS Rao","year":"2000","unstructured":"Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR et al (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054\u20131058","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"1142_CR22","first-page":"N75","volume":"17","author":"DS Rao","year":"2002","unstructured":"Rao DS, Agarwal G, Talpos GB, Phillips ER, Bandeira F, Mishra SK et al (2002) Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res 17(Suppl 2):N75\u2013N80","journal-title":"J Bone Miner Res"},{"key":"1142_CR23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.1995.tb02043.x","volume":"43","author":"CV Harinarayan","year":"1995","unstructured":"Harinarayan CV, Gupta N, Kochupillai N (1995) Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf) 43:351\u2013358","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1142_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7326\/0003-4819-108-1-151_2","volume":"108","author":"AM Parfitt","year":"1988","unstructured":"Parfitt AM, Rao DS, Kleerekoper M (1988) Screening for primary hyperparathyroidism. Ann Intern Med 108:151\u2013152","journal-title":"Ann Intern Med"},{"key":"1142_CR25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ncpendmet0265","volume":"2","author":"SJ Silverberg","year":"2006","unstructured":"Silverberg SJ, Bilezikian JP (2006) The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab 2:494\u2013503","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1142_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP, Khan AA, Potts JT Jr (2009) Third International Workshop on the Management of Asymptomatic Primary H. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335\u2013339","journal-title":"J Clin Endocrinol Metab"},{"key":"1142_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L et al (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28:1\u201319","journal-title":"Osteoporos Int"},{"key":"1142_CR28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/S0004-27302006000400011","volume":"50","author":"F Bandeira","year":"2006","unstructured":"Bandeira F, Griz L, Caldas G, Bandeira C, Freese E (2006) From mild to severe primary hyperparathyroidism: the Brazilian experience. Arq Bras Endocrinol Metabol 50:657\u2013663","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"1142_CR29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/ijem.IJEM_445_16","volume":"22","author":"VJ Mallikarjuna","year":"2018","unstructured":"Mallikarjuna VJ, Mathew V, Ayyar V, Bantwal G, Ganesh V, George B et al (2018) Five-year retrospective study on primary hyperparathyroidism in South India: emerging roles of minimally invasive parathyroidectomy and preoperative localization with methionine positron emission tomography-computed tomography scan. Indian J Endocrinol Metab 22:355\u2013361","journal-title":"Indian J Endocrinol Metab"},{"key":"1142_CR30","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2169\/internalmedicine.53.2133","volume":"53","author":"A Ogo","year":"2014","unstructured":"Ogo A, Sakaki Y, Saito R, Sakamoto R, Matoba Y (2014) A pilot study to examine the management of asymptomatic hyperparathyroidism in Japanese patients in accordance with the guidelines for asymptomatic PHPT proposed at the Third International Workshop in 2008. Intern Med 53:1749\u20131754","journal-title":"Intern Med"},{"key":"1142_CR31","doi-asserted-by":"crossref","first-page":"952426","DOI":"10.1155\/2012\/952426","volume":"2012","author":"P Prasarttong-Osoth","year":"2012","unstructured":"Prasarttong-Osoth P, Wathanaoran P, Imruetaicharoenchoke W, Rojananin S (2012) Primary hyperparathyroidism: 11-year experience in a single institute in Thailand. Int J Endocrinol 2012:952426","journal-title":"Int J Endocrinol"},{"key":"1142_CR32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1507\/endocrj.44.595","volume":"44","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Sugimoto T, Chihara K (1997) Clinical and biochemical presentation of primary hyperparathyroidism in Kansai district of Japan. Endocr J 44:595\u2013601","journal-title":"Endocr J"},{"key":"1142_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/balkanmedj.2015.0865","volume":"34","author":"O Makay","year":"2017","unstructured":"Makay O, Ozcinar B, Simsek T, Arici C, Gungor B, Ozbas S et al (2017) Regional clinical and biochemical differences among patients with primary hyperparathyroidism. Balkan Med J 34:28\u201334","journal-title":"Balkan Med J"},{"key":"1142_CR34","first-page":"1360","volume":"69","author":"MI Siddiqui","year":"2019","unstructured":"Siddiqui MI, Pasha HA, Asad R, Talati JJ (2019) Changing paradigms in the surgical management of hyperparathyroidism at a tertiary care hospital in a developing country. J Pak Med Assoc 69:1360\u20131364","journal-title":"J Pak Med Assoc"},{"key":"1142_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/2230-8210.172285","volume":"20","author":"YK Tay","year":"2016","unstructured":"Tay YK, Khoo J, Chandran M (2016) Surgery or no surgery: What works best for the kidneys in primary hyperparathyroidism? A study in a multi-ethnic Asian population. Indian J Endocrinol Metab 20:55\u201361","journal-title":"Indian J Endocrinol Metab"},{"key":"1142_CR36","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40618-018-0879-z","volume":"41","author":"F Saponaro","year":"2018","unstructured":"Saponaro F, Cetani F, Repaci A, Pagotto U, Cipriani C, Pepe J et al (2018) Clinical presentation and management of patients with primary hyperparathyroidism in Italy. J Endocrinol Investig 41:1339\u20131348","journal-title":"J Endocrinol Investig"},{"key":"1142_CR37","doi-asserted-by":"crossref","first-page":"7617254","DOI":"10.1155\/2019\/7617254","volume":"2019","author":"C Aresta","year":"2019","unstructured":"Aresta C, Passeri E, Corbetta S (2019) Symptomatic hypercalcemia in patients with primary hyperparathyroidism is associated with severity of disease, polypharmacy, and comorbidity. Int J Endocrinol 2019:7617254","journal-title":"Int J Endocrinol"},{"key":"1142_CR38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","volume":"16","author":"SJ Silverberg","year":"2013","unstructured":"Silverberg SJ, Walker MD, Bilezikian JP (2013) Asymptomatic primary hyperparathyroidism. J Clin Densitom 16:14\u201321","journal-title":"J Clin Densitom"},{"key":"1142_CR39","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"Walker MD, Cong E, Lee JA, Kepley A, Zhang C, McMahon DJ et al (2015) Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. J Clin Endocrinol Metab 100:3443\u20133451","journal-title":"J Clin Endocrinol Metab"},{"key":"1142_CR40","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415\u20135422","journal-title":"J Clin Endocrinol Metab"},{"key":"1142_CR41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/172460089701200304","volume":"12","author":"F Locchi","year":"1997","unstructured":"Locchi F, Tommasi M, Brandi ML, Tonelli F, Meldolesi U (1997) A controversial problem: is there a relationship between parathyroid hormone level and parathyroid size in primary hyperparathyroidism? Int J Biol Mark 12:106\u2013111","journal-title":"Int J Biol Mark"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01142-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-020-01142-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01142-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:41:37Z","timestamp":1630971697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-020-01142-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1142"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01142-w","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Ethics committee, Postgraduate Institute of Medical Education and Research, Chandigarh India (INT\/IEC\/2016\/2254 dated 27-09-2016). Informed written consent was obtained from all study participants. The study was carried out in accordance with the approved institutional and international research ethics guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}